Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro

Barnes, 1998, Anti-inflammatory actions of glucocorticoids: molecular mechanisms, Clin Sci, 94, 557, 10.1042/cs0940557 Vayssière, 1997, Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo, Mol Endocrinol, 11, 1245, 10.1210/mend.11.9.9979 Schäcke, 2005, Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index, Curr Opin Investig Drugs, 6, 503 Longui, 2007, Glucocorticoid therapy: minimizing side effects, J Pediatr (Rio J), 83, S163, 10.1590/S0021-75572007000700007 Liu, 1992, Recent advances on ginseng research in China, J Ethnopharmacol, 36, 27, 10.1016/0378-8741(92)90057-X Ling, 2005, Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticoid receptor, Gen Comp Endocrinol, 140, 203, 10.1016/j.ygcen.2004.11.003 Kim, 2013, Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver, J Ginseng Res, 37, 54, 10.5142/jgr.2013.37.54 Joh, 2011, Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—the key step of inflammation, Biochem Pharmacol, 82, 278, 10.1016/j.bcp.2011.05.003 Lee, 1997, Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor, Mol Cell Endocrinol, 133, 135, 10.1016/S0303-7207(97)00160-3 Chan, 2002, Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng, J Clin Endocrinol Metab, 87, 3691, 10.1210/jcem.87.8.8717 Leung, 2006, Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells, FEBS Lett, 580, 3211, 10.1016/j.febslet.2006.04.080 Rhule, 2006, Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells, J Ethnopharmacol, 106, 121, 10.1016/j.jep.2005.12.012 Wu, 2007, Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia, Int Immunopharmacol, 7, 313, 10.1016/j.intimp.2006.04.021 Du, 2011, Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects, J Immunol, 187, 942, 10.4049/jimmunol.1002579 Denizot, 1986, Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability, J Immunol Methods, 89, 271, 10.1016/0022-1759(86)90368-6 Ishihara, 2000, Tryptanthrin inhibits nitric oxide and prostaglandin E (2) synthesis by murine macrophages, Eur J Pharmacol, 407, 197, 10.1016/S0014-2999(00)00674-9 Berenbaum, 1989, What is synergy?, Pharmacol Rev, 41, 93 Chou, 2006, Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies, Pharmacol Rev, 58, 621, 10.1124/pr.58.3.10 Raetz, 2002, Lipopolysaccharide endotoxins, Annu Rev Biochem, 71, 635, 10.1146/annurev.biochem.71.110601.135414 Appleton, 1996, Induction of cyclo-oxygenase and nitric oxide synthase in inflammation, Adv Pharmacol, 35, 27, 10.1016/S1054-3589(08)60274-4 Stefanovic-Racic, 1993, Nitric oxide and arthritis, Arthritis Rheum, 36, 1036, 10.1002/art.1780360803 Morgan, 2008, TNF alpha and reactive oxygen species in necrotic cell death, Cell Res, 18, 343, 10.1038/cr.2008.31 Cope, 1997, The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire, Res Immunol, 148, 307, 10.1016/S0923-2494(97)87239-2 Kim, 2007, TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death, Mol Cell, 26, 675, 10.1016/j.molcel.2007.04.021 Sakon, 2003, NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death, EMBO J, 22, 3898, 10.1093/emboj/cdg379 Baud, 2011, Signal transduction by tumor necrosis factor and its relatives, Trends Cell Biol, 9, 327 Andrade, 2011, Role of TNF-alpha during central sensitization in preclinical studies, Neurol Sci, 32, 757, 10.1007/s10072-011-0599-z Rigaud, 1991, In vivo footprinting of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor, Cell, 67, 977, 10.1016/0092-8674(91)90370-E Zaret, 1984, Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element, Cell, 38, 29, 10.1016/0092-8674(84)90523-3 Richard-Foy, 1987, Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter, EMBO J, 6, 2321, 10.1002/j.1460-2075.1987.tb02507.x John, 2008, Interaction of the glucocorticoid receptor with the chromatin landscape, Mol Cel, 29, 611, 10.1016/j.molcel.2008.02.010 John, 2011, Chromatin accessibility pre-determines glucocorticoid receptor binding patterns, Nat Genet, 43, 264, 10.1038/ng.759 So, 2007, Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor, PLoS Genet, 3, 94, 10.1371/journal.pgen.0030094 John, 2009, Kinetic complexity of the global response to glucocorticoid receptor action, Endocrinology, 150, 1766, 10.1210/en.2008-0863 Xin, 2011, Escin attenuates acute lung injury induced by endotoxin in mice, Eur J Pharm Sci, 42, 73, 10.1016/j.ejps.2010.10.008 Zou, 2013, Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes, J Surg Res, 183, 760, 10.1016/j.jss.2013.01.068 Meduri, 1998, Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way?, Chest, 114, 355, 10.1378/chest.114.2.355-a Huang, 1987, Study on glucocorticoid receptors during intestinal ischemia shock and septic shock, Circ Shock, 23, 27 Barnes, 1995, Glucocorticoid resistance in asthma, Am J Respir Crit Care Med, 152, S125, 10.1164/ajrccm/152.6_Pt_2.S125 Molijn, 1995, Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock, Clin Endocrinol (Oxf), 43, 197, 10.1111/j.1365-2265.1995.tb01915.x